Biotech Specialty Pharma

ALBA Therapeutics Corporation

Suite 400, 800 West Baltimore Street
Baltimore, MD 21201 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Pharmaceuticals for the treatment of inflammatory and immune mediated diseases.

Management Bruce A. Peacock, Chief Executive Officer; Sefik Alkan, PhD, Executive Vice President, Discovery; Jeffrey W. Church, CPA, Chief Financial Officer; Anne Shiflett, CPA, Vice President, Finance & Administration; Sharon Rowland, PhD, RAC, Vice President, Regulatory Affairs & Quality; Francisco Leon, MD, PhD, Vice President, Clinical Development & Medical Affairs; Wendy Perrow, MBA, Vice President, Marketing & Alliance Management; Linda Arterburn, PhD, Vice President, Preclinical Development & Program Management; Roberto N. Allen, Esq., Vice President, Legal Affairs & Intellectual Property; Mark Ginski, PhD, Senior Director, Product & Analytical Development

Click here for Financial Data
Keywords: inflammatory, immune, zonulin, antagonist, gastrointestinal, metabolic, pulmonary, renal


Updated: Aug. 05, 2011


Alba Therapeutics Corporation is focused on the development, production and marketing of pharmaceuticals for the treatment of inflammatory and immune mediated diseases.......view more

Products / Services

Current therapeutic areas of focus for Alba's zonulin antagonists include immune-based disorders, a diverse classification that encompasses gastrointestinal, metabolic, pulmonary, and renal disease st......view more